Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.52 |
| ▸ | USP2 | O75604 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | MMP9 | P14780 | 1/20 | 0.52 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | CA2 | P00918 | 3/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.35 |
| ▸ | MITF | O75030 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.34 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.34 |
| ▸ | MGLL | Q99685 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7597791 | 0.98 | KDM4E (0.50) | KDM4EUSP2ALDH1A1LMNAMMP9 | |
| SCHEMBL4970012 | 0.95 | KDM4E (0.48) | KDM4EUSP2ALDH1A1LMNAMMP9 | |
| SCHEMBL3863603 | 0.87 | CA1 (0.43) | KDM4EUSP2ALDH1A1LMNAMMP9 | |
| SCHEMBL26316551 | 0.84 | ALDH1A1 (0.54) | KDM4EUSP2ALDH1A1LMNAMMP9 | |
| SCHEMBL16825858 | 0.83 | TSHR (0.52) | KDM4EUSP2ALDH1A1LMNAMMP9 | |
| SCHEMBL11279959 | 0.83 | TSHR (0.52) | KDM4EUSP2ALDH1A1LMNAMMP9 | |
| SCHEMBL2658522 | 0.82 | KDM4E (0.56) | KDM4EUSP2ALDH1A1LMNAMMP9 | |
| SCHEMBL1843955 | 0.81 | APLNR (0.51) | KDM4EUSP2ALDH1A1LMNAMMP9 | |
| SCHEMBL4802236 | 0.81 | LMNA (0.46) | KDM4EUSP2ALDH1A1LMNAMMP9 | |
| SCHEMBL23014971 | 0.81 | KDM4E (0.54) | KDM4EUSP2ALDH1A1LMNAMMP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2308910-B1 | POLYMER COMPOUND AND LIGHT-EMITTING ELEMENT USING SAME | SUMITOMO CHEMICAL CO (JP) | 2017-03-01 | — | — | EP | disclosed |
| US-8993124-B2 | Polymer compound comprising aryl repeating units with crosslinking pendent groups and light-emitting element using same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2015-03-31 | — | — | US | disclosed |
| US-8993124-B2 | Polymer compound comprising aryl repeating units with crosslinking pendent groups and light-emitting element using same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2015-03-31 | — | — | US | disclosed |
| US-20110127516-A1 | POLYMER COMPOUND AND LIGHT-EMITTING ELEMENT USING SAME | SUMITOMO CHEMICAL COMPANY ,LIMITED (JP) | 2011-06-02 | — | — | US | disclosed |
| WO-2008106204-A1 | MACROLIDE COMPOUNDS AND METHODS OF MAKING AND USING THE SAME | RIB-X-PHARMACEUTICALS, INC. (US) | 2008-09-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110127516-A1 | POLYMER COMPOUND AND LIGHT-EMITTING ELEMENT USING SAME | RER1, NAP1L1, CRY1 | KDM4E 1822/4885USP2 3848/4885ALDH1A1 730/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.